MDT
62
3
ISRG
76
2
NTAP
66
2
GLW
46
4
HBAN
56
2
CMG
67
3
JPM
67
4
HD
55
8
FE
52
3
GRMN
64
2
AVGO
22
2
ROK
47
-8
CSX
57
6
PWR
72
2
AEE
64
4
AZO
48
2
EOG
56
-2
EMN
56
7
F
47
4
MRO
40
-15
MDT
62
3
ISRG
76
2
NTAP
66
2
GLW
46
4
HBAN
56
2
CMG
67
3
JPM
67
4
HD
55
8
FE
52
3
GRMN
64
2
AVGO
22
2
ROK
47
-8
CSX
57
6
PWR
72
2
AEE
64
4
AZO
48
2
EOG
56
-2
EMN
56
7
F
47
4
MRO
40
-15
Financhill
Back

Regencell Bioscience Holdings 10K Form

Sell
20

RGC
Regencell Bioscience Holdings

Last Price:
5.83
Seasonality Move:
-4.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RGC News And Ratings

See the #1 stock for the next 7 days that we like better than RGC

RGC Financial Statistics

Sales & Book Value

Annual Sales: $3.16B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.63
Price / Book: 8.95

Profitability

EPS (TTM): -0.33000
Net Income (TTM): $-4.3M
Gross Margin: $1.97B
Return on Equity: 0%
Return on Assets: 0%

Regencell Bioscience Holdings Earnings Forecast

Key Regencell Bioscience Holdings Financial Ratios

  • The Gross Profit Margin over the past 13 years for RGC is 62.33%.
  • The Selling, General & Administrative Expenses for RGC have been equal to 16.23% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Regencell Bioscience Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RGC
Website: regencellbioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RGC Technical Analysis vs Fundamental Analysis

Sell
20
Regencell Bioscience Holdings (RGC) is a Sell

Is Regencell Bioscience Holdings a Buy or a Sell?